Written from the studies on PubMed, searched on 2026. nov. 11.. Every number below comes from a study listed under Sources.
What people read
Posts online say that Stem cell treatment helps with Duchenne muscular dystrophy.
What has been studied
- 0In people
- 32In animals
- 33Only in the lab
What the studies found
Stem cell treatment has been studied for Duchenne muscular dystrophy in animals, not yet in people.
We found 103 published papers on Stem cell treatment and Duchenne muscular dystrophy. They were published between 1991 and 2026.
0 of them are studies in people (0 randomised trials), 28 are reviews, 32 are studies in animals and 33 are studies only in the lab.
The most important ones are listed under Sources.
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies.2025 · Cell Mol Life Sci · Review
- [Muscle stem cells and metabolism in Duchenne muscular dystrophy, focus on AMPK].2024 · Med Sci (Paris) · Review
- Muscle stem cell dysfunction in rhabdomyosarcoma and muscular dystrophy.2024 · Curr Top Dev Biol · Review
- Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.2023 · Int J Mol Sci · Review
- Application of Stem Cell Therapy During the Treatment of HIV/AIDS and Duchenne Muscular Dystrophy.2022 · Curr Stem Cell Res Ther · Review
- Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy.2022 · Cells Tissues Organs · Review
- Impaired stem cell migration and divisions in Duchenne muscular dystrophy revealed by live imaging.2026 · Nat Commun · In animals
- Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis.2025 · Nat Commun · In animals
- Continuous adipose-derived stem cell therapy from the neonatal stage effectively reduces Duchenne muscular dystrophy symptoms in rats.2025 · Stem Cell Res Ther · In animals
- Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies.2025 · Mol Ther · In animals
- Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity.2025 · Cell Death Dis · In animals
- Skeletal muscle stem cells modulate niche function in Duchenne muscular dystrophy mouse through YY1-CCL5 axis.2025 · Nat Commun · In animals
- Derivation of a new induced pluripotent stem cell line ORIONi004-A for modelling Duchenne muscular dystrophy.2026 · Stem Cell Res · In the lab
- Generation and characterization of three human induced pluripotent stem cell lines from patients with Duchenne muscular dystrophy.2026 · Stem Cell Res · In the lab
- Generation of an induced pluripotent stem cell line (NCHi026-A) from a patient with a partial deletion of exon 55 in the DMD gene.2026 · Stem Cell Res · In the lab
- Generation of an Induced Pluripotent Stem Cell Line from a Duchenne Muscular Dystrophy Patient Carrying the DMD p.Ser429Ter (c.1286C>G) Nonsense Mutation.2026 · Bull Exp Biol Med · In the lab
- Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches.2026 · Curr Pharm Des · Other paper
- Generation of human induced pluripotent stem cell line derived from Becker muscular dystrophy patient with CRISPR/Cas9-mediated correction of DMD gene mutation.2024 · Stem Cell Res · Other paper
- In vitro myogenesis activation of specific muscle-derived stem cells from patients with Duchenne muscular dystrophy.2023 · Transpl Immunol · Other paper
- CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model.2022 · Neuromuscul Disord · Other paper